VTMC yields 18181.82% · ABBV yields 3.06%● Live data
📍 VTMC pulled ahead of the other in Year 1
Combined, VTMC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VTMC + ABBV for your $10,000?
Valentine Mark Corporation provides various services for the organizations in healthcare, hospitality and financial services industries. The company offers strategic and operational advisory services; and management and development services, including clinical guidance regarding developing technologies, commercial strategy for development of healthcare management companies, strategic guidance, financial planning for operations and reimbursement, and regulatory and compliance support services. It also provides investment banking services comprising mergers and acquisition services, such as reorganizations and restructurings, recapitalizations, buyouts, sell side and buy side advisory services, and valuations and fairness opinions; financial advisory services, which include credit rating solicitation and maintenance, and strategic capital planning services; and financing services consisting of term loans, real estate loans, revolving credit facilities, mezzanine financing, and private placements of equity and debt to healthcare clients. In addition, the company offers financial and management solutions that comprise hospitality venture funding, and facility development and management for the hospital industry. Further, it provides corporate finance and private equity advisory services, including capital raising; mergers and acquisitions; management team development; infrastructure development for operations; filing, auditing, and reporting assistance for publicly-traded companies; formation of special-purpose vehicles for transactions; private equity and portfolio management; company formation; exchange-listing services for companies seeking to go public; and healthcare and hospitality management services. The company was formerly known as London Pacific & Partners, Inc. and changed its name to Valentine Mark Corporation in March 2015. Valentine Mark Corporation was incorporated in 1968 and is based in New York, New York.
Full VTMC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.